NCT01809041

Brief Summary

Post-operative cognitive dysfunction (POCD) is a fairly well-documented clinical phenomenon. Most patients will receive general anesthesia during surgery. Two groups of general anesthetics are used for this purpose. We hypothesize that the incidence of POCD is not different in patients received intravenous anesthetics only or sevoflurane (a volatile anesthetic-based general anesthesia) for their major intra-abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
684

participants targeted

Target at P75+ for phase_4

Timeline
Completed

Started Mar 2013

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2013

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

March 6, 2013

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 12, 2013

Completed
6.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

6.1 years

First QC Date

March 6, 2013

Last Update Submit

June 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of patients with postoperative cognitive dysfunction (POCD) (POCD is a composite outcome measure)

    Incidence of POCD in patients will be determined by a set of cognitive tests.

    At 7 days after the surgery

Secondary Outcomes (1)

  • Number of patients with postoperative cognitive dysfunction (POCD) (POCD is a composite outcome measure)

    At 3 months after the surgery

Other Outcomes (6)

  • Time for bowel function return after surgery

    up to 2 weeks after the surgery

  • Degree of increase of stress hormones

    Up to 1 day after the surgery

  • Length of hospital stay

    Up to 3 months after the surgery

  • +3 more other outcomes

Study Arms (2)

Sevoflurane & remifentanil

EXPERIMENTAL

sevoflurane at 0.5 to 1.5 minimum alveolar concentrations plus remifentanil (0.1 - 0.5 µg/kg/min) during the surgery.

Drug: SevofluraneDrug: remifentanil

propofol & remifentanil

ACTIVE COMPARATOR

propofol (50 - 150 µg/kg/min) and remifentanil (0.1 - 0.5 µg/kg/min)

Drug: propofolDrug: remifentanil

Interventions

Sevoflurane & remifentanil
propofol & remifentanil
Sevoflurane & remifentanilpropofol & remifentanil

Eligibility Criteria

Age60 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • major elective gastrointestinal, gynecological, prostate or bladder surgery patients who are ≥ 60 years old.
  • the surgery is laparoscopic surgery and is expected to last for ≥ 2 hours under general anesthesia and the patient will stay in hospital for at least 7 days after surgery.
  • lack of serious hearing and vision impairment and be able to read so that neurobehavioral tests can be performed.

You may not qualify if:

  • Patients are not expected to be alive for longer than 3 months.
  • Mini-mental State Examination (MMSE) \[18\] score ≤ 23.
  • history of dementia, psychiatric illness or any diseases of central nervous system.
  • current use of sedatives or antidepressant.
  • alcoholism and drug dependence.
  • patients previously included in this study (for patients who have second intra-abdominal surgery during the study period).
  • difficult to follow up or patients with poor compliance.
  • uncontrolled hypertension (\> 180/100 mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-Sen Memorial Hospital

Guangzhou, Guangdong, 510120, China

Location

Related Publications (5)

  • Monk TG, Weldon BC, Garvan CW, Dede DE, van der Aa MT, Heilman KM, Gravenstein JS. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology. 2008 Jan;108(1):18-30. doi: 10.1097/01.anes.0000296071.19434.1e.

    PMID: 18156878BACKGROUND
  • Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA; Neurological Outcome Research Group and the Cardiothoracic Anesthesiology Research Endeavors Investigators. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001 Feb 8;344(6):395-402. doi: 10.1056/NEJM200102083440601.

    PMID: 11172175BACKGROUND
  • Steinmetz J, Christensen KB, Lund T, Lohse N, Rasmussen LS; ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology. 2009 Mar;110(3):548-55. doi: 10.1097/ALN.0b013e318195b569.

    PMID: 19225398BACKGROUND
  • Rasmussen LS, Johnson T, Kuipers HM, Kristensen D, Siersma VD, Vila P, Jolles J, Papaioannou A, Abildstrom H, Silverstein JH, Bonal JA, Raeder J, Nielsen IK, Korttila K, Munoz L, Dodds C, Hanning CD, Moller JT; ISPOCD2(International Study of Postoperative Cognitive Dysfunction) Investigators. Does anaesthesia cause postoperative cognitive dysfunction? A randomised study of regional versus general anaesthesia in 438 elderly patients. Acta Anaesthesiol Scand. 2003 Mar;47(3):260-6. doi: 10.1034/j.1399-6576.2003.00057.x.

    PMID: 12648190BACKGROUND
  • Williams-Russo P, Sharrock NE, Mattis S, Szatrowski TP, Charlson ME. Cognitive effects after epidural vs general anesthesia in older adults. A randomized trial. JAMA. 1995 Jul 5;274(1):44-50.

    PMID: 7791257BACKGROUND

MeSH Terms

Interventions

SevofluranePropofolRemifentanil

Intervention Hierarchy (Ancestors)

Methyl EthersEthersOrganic ChemicalsHydrocarbons, FluorinatedHydrocarbons, HalogenatedHydrocarbonsPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicPropionatesAcids, AcyclicCarboxylic AcidsPiperidinesHeterocyclic Compounds, 1-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Visiting Professor

Study Record Dates

First Submitted

March 6, 2013

First Posted

March 12, 2013

Study Start

March 1, 2013

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations